Masato Shingyoji

1.7k total citations
67 papers, 1.3k citations indexed

About

Masato Shingyoji is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Masato Shingyoji has authored 67 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Pulmonary and Respiratory Medicine, 33 papers in Oncology and 18 papers in Molecular Biology. Recurrent topics in Masato Shingyoji's work include Lung Cancer Treatments and Mutations (28 papers), Lung Cancer Research Studies (16 papers) and Lung Cancer Diagnosis and Treatment (12 papers). Masato Shingyoji is often cited by papers focused on Lung Cancer Treatments and Mutations (28 papers), Lung Cancer Research Studies (16 papers) and Lung Cancer Diagnosis and Treatment (12 papers). Masato Shingyoji collaborates with scholars based in Japan, United States and Canada. Masato Shingyoji's co-authors include Toshihiko Iizasa, Meiji Itakura, Takahiro Nakajima, Hideki Kimura, Tsukasa Sakaida, Toshihiko Iuchi, Yuzo Hasegawa, Kazuhiro Yasufuku, Liang-Hao Ding and Fanqing Chen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Masato Shingyoji

63 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masato Shingyoji Japan 15 847 514 382 183 181 67 1.3k
Jianlin Xu China 22 935 1.1× 912 1.8× 453 1.2× 316 1.7× 143 0.8× 99 1.7k
Jingyu Yu United States 15 439 0.5× 871 1.7× 286 0.7× 143 0.8× 177 1.0× 27 1.3k
Ramon Andrade de Mello Portugal 21 565 0.7× 745 1.4× 477 1.2× 314 1.7× 87 0.5× 89 1.4k
Edgar Ben‐Josef United States 19 973 1.1× 408 0.8× 324 0.8× 176 1.0× 339 1.9× 34 1.6k
Jin‐Hyuk Choi South Korea 18 483 0.6× 488 0.9× 318 0.8× 147 0.8× 64 0.4× 73 944
Y. Ichinose Japan 20 922 1.1× 721 1.4× 211 0.6× 102 0.6× 111 0.6× 78 1.3k
Chung-Tsen Hsueh United States 19 305 0.4× 556 1.1× 416 1.1× 200 1.1× 43 0.2× 55 1.2k
Zhenfa Zhang China 20 464 0.5× 411 0.8× 461 1.2× 319 1.7× 94 0.5× 90 1.2k
Ulla Kasten-Pisula Germany 15 300 0.4× 389 0.8× 538 1.4× 197 1.1× 145 0.8× 17 883

Countries citing papers authored by Masato Shingyoji

Since Specialization
Citations

This map shows the geographic impact of Masato Shingyoji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masato Shingyoji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masato Shingyoji more than expected).

Fields of papers citing papers by Masato Shingyoji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masato Shingyoji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masato Shingyoji. The network helps show where Masato Shingyoji may publish in the future.

Co-authorship network of co-authors of Masato Shingyoji

This figure shows the co-authorship network connecting the top 25 collaborators of Masato Shingyoji. A scholar is included among the top collaborators of Masato Shingyoji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masato Shingyoji. Masato Shingyoji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Udagawa, Hibiki, Shingo Matsumoto, Hiroki Izumi, et al.. (2024). Efficacy of immunotherapy in first-line treatment for non-small cell lung cancer with HER2 mutation: Results from LC-SCRUM-Asia.. Journal of Clinical Oncology. 42(16_suppl). 8629–8629. 1 indexed citations
2.
Iuchi, Toshihiko, et al.. (2024). 1332P Effects of immune checkpoint inhibitors for EGFR-wild/ALK-negative NSCLC patients with untreated brain metastases. Annals of Oncology. 35. S845–S846. 1 indexed citations
3.
Shingyoji, Masato, Takao Morinaga, Yuji Tada, et al.. (2021). An MDM2 inhibitor achieves synergistic cytotoxic effects with adenoviruses lacking E1B55kDa gene on mesothelioma with the wild-type p53 through augmenting NFI expression. Cell Death and Disease. 12(7). 663–663. 7 indexed citations
4.
Shingyoji, Masato, Takao Morinaga, Yuji Tada, et al.. (2020). Combination of a p53-activating CP-31398 and an MDM2 or a FAK inhibitor produces growth suppressive effects in mesothelioma with wild-type p53 genotype. APOPTOSIS. 25(7-8). 535–547. 6 indexed citations
5.
Nakamura, Atsushi, Hibiki Udagawa, Shingo Matsumoto, et al.. (2017). Prevalence of NTRK gene fusions in a large cohort of Japanese patients with lung cancer. Annals of Oncology. 28. x126–x126. 3 indexed citations
6.
Nakajima, Takahiro, Masato Shingyoji, Takashi Anayama, et al.. (2016). Spectrum Analysis of Endobronchial Ultrasound Radiofrequency of Lymph Nodes in Patients With Lung Cancer. CHEST Journal. 149(6). 1393–1399. 11 indexed citations
7.
Jiang, Yuanyuan, Kiyoko Kawamura, Takao Morinaga, et al.. (2016). Combination of a third generation bisphosphonate and replication-competent adenoviruses augments the cytotoxicity on mesothelioma. BMC Cancer. 16(1). 455–455. 1 indexed citations
8.
9.
Takei, Yoshio, Shinya Okamoto, K Kawamura, et al.. (2015). Expression of p53 synergistically augments caspases-mediated apoptosis induced by replication-competent adenoviruses in pancreatic carcinoma cells. Cancer Gene Therapy. 22(9). 445–453. 6 indexed citations
10.
Kawamura, Kiyoko, Shinya Okamoto, Masato Shingyoji, et al.. (2015). Cytotoxic effects of replication-competent adenoviruses on human esophageal carcinoma are enhanced by forced p53 expression. BMC Cancer. 15(1). 464–464. 2 indexed citations
11.
Okamoto, Shinya, Yuanyuan Jiang, K Kawamura, et al.. (2014). Zoledronic acid induces apoptosis and S-phase arrest in mesothelioma through inhibiting Rab family proteins and topoisomerase II actions. Cell Death and Disease. 5(11). e1517–e1517. 30 indexed citations
12.
Takiguchi, Yuichi, Shunichiro Iwasawa, Koichi Minato, et al.. (2014). Phase II study of carboplatin, docetaxel and bevacizumab for chemotherapy-naïve patients with advanced non-squamous non-small cell lung cancer. International Journal of Clinical Oncology. 20(4). 659–667. 2 indexed citations
13.
Ma, Guangyu, K Kawamura, Shinya Okamoto, et al.. (2014). Combination of adenoviruses expressing melanoma differentiation-associated gene-7 and chemotherapeutic agents produces enhanced cytotoxicity on esophageal carcinoma. Cancer Gene Therapy. 21(1). 31–37. 9 indexed citations
14.
Shingyoji, Masato, Dai Ikebe, Meiji Itakura, et al.. (2013). Pulmonary Artery Sarcoma Diagnosed by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration. The Annals of Thoracic Surgery. 96(2). e33–e35. 15 indexed citations
15.
Okamoto, Shinya, Yuanyuan Jiang, Kiyoko Kawamura, et al.. (2013). Zoledronic Acid Produces Combinatory Anti-Tumor Effects with Cisplatin on Mesothelioma by Increasing p53 Expression Levels. PLoS ONE. 8(3). e60297–e60297. 8 indexed citations
16.
Shingyoji, Masato, Toshihiko Iizasa, Masahiko Higashiyama, et al.. (2013). The significance and robustness of a plasma free amino acid (PFAA) profile-based multiplex function for detecting lung cancer. BMC Cancer. 13(1). 77–77. 54 indexed citations
17.
Kawamura, K, Yuanyuan Jiang, Masato Shingyoji, et al.. (2013). Heat-shock protein 90 inhibitors synergistically enhance melanoma differentiation-associated gene-7-mediated cell killing of human pancreatic carcinoma. Cancer Gene Therapy. 20(12). 663–670. 6 indexed citations
18.
Nakajima, Takahiro, Takashi Anayama, Terumoto Koike, et al.. (2012). Endobronchial Ultrasound Doppler Image Features Correlate with mRNA Expression of hif1-α and vegf-c in Patients with Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 7(11). 1661–1667. 22 indexed citations
19.
Shingyoji, Masato, Hajime Kageyama, Tsukasa Sakaida, et al.. (2011). Detection of Epithelial Growth Factor Receptor Mutations in Cerebrospinal Fluid from Patients with Lung Adenocarcinoma Suspected of Neoplastic Meningitis. Journal of Thoracic Oncology. 6(7). 1215–1220. 35 indexed citations
20.
Shingyoji, Masato, et al.. (2005). Quantum dots-based reverse phase protein microarray. Talanta. 67(3). 472–478. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jianlin Xu Breakdown of academic impact, for papers by Jingyu Yu Breakdown of academic impact, for papers by Ramon Andrade de Mello Breakdown of academic impact, for papers by Edgar Ben‐Josef Breakdown of academic impact, for papers by Jin‐Hyuk Choi Breakdown of academic impact, for papers by Y. Ichinose Breakdown of academic impact, for papers by Chung-Tsen Hsueh Breakdown of academic impact, for papers by Zhenfa Zhang Breakdown of academic impact, for papers by Ulla Kasten-Pisula
Rankless by CCL
2026